Chemomab Therapeutics Ltd. ( CMMB) - Key Metrics
CMMB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.28 | $0 | $0 |
| 2026Q1 | $0 | -$0.22 | $0 | $0 |
| 2025Q4 | $0 | -$0.24 | -$1.43 | -$1.43 |
| 2025Q3 | $0 | -$0.28 | $0 | $0 |
| 2025Q2 | $0 | -$0.36 | $0 | $0 |
CMMB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.45 |
| 2026Q1 | 0% | -1.78 |
| 2025Q4 | 0% | -1.72 |
| 2025Q3 | 0% | -2.33 |
| 2025Q2 | 0% | -3.22 |
CMMB
Price: $2.58
52 week price:
Earnings Per Share: -1.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 37000
Market Capitalization: 17.4 million